Citigroup’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Sell |
46,536
-187,636
| -80% | -$10M | ﹤0.01% | 1871 |
|
|
2025
Q1 | $9.48M | Buy |
234,172
+146,255
| +166% | +$5.92M | ﹤0.01% | 1010 |
|
|
2024
Q4 | $2.45M | Buy |
87,917
+36,036
| +69% | +$1M | ﹤0.01% | 1982 |
|
|
2024
Q3 | $1.49M | Buy |
51,881
+22,612
| +77% | +$649K | ﹤0.01% | 2267 |
|
|
2024
Q2 | $687K | Sell |
29,269
-226,165
| -89% | -$5.31M | ﹤0.01% | 2500 |
|
|
2024
Q1 | $6.45M | Buy |
255,434
+66,982
| +36% | +$1.69M | ﹤0.01% | 1113 |
|
|
2023
Q4 | $4.4M | Buy |
188,452
+91,962
| +95% | +$2.15M | ﹤0.01% | 1197 |
|
|
2023
Q3 | $4.88M | Buy |
96,490
+23,955
| +33% | +$1.21M | ﹤0.01% | 1047 |
|
|
2023
Q2 | $3.39M | Sell |
72,535
-60,982
| -46% | -$2.85M | ﹤0.01% | 1330 |
|
|
2023
Q1 | $5.11M | Buy |
133,517
+50,458
| +61% | +$1.93M | ﹤0.01% | 1114 |
|
|
2022
Q4 | $4.55M | Buy |
83,059
+80,860
| +3,677% | +$4.43M | ﹤0.01% | 1102 |
|
|
2022
Q3 | $75K | Sell |
2,199
-1,878
| -46% | -$64.1K | ﹤0.01% | 3513 |
|
|
2022
Q2 | $39K | Sell |
4,077
-8,742
| -68% | -$83.6K | ﹤0.01% | 3961 |
|
|
2022
Q1 | $182K | Sell |
12,819
-37,025
| -74% | -$526K | ﹤0.01% | 3447 |
|
|
2021
Q4 | $1.05M | Buy |
49,844
+18,563
| +59% | +$393K | ﹤0.01% | 2497 |
|
|
2021
Q3 | $699K | Sell |
31,281
-44,563
| -59% | -$996K | ﹤0.01% | 2667 |
|
|
2021
Q2 | $1.88M | Buy |
75,844
+15,717
| +26% | +$390K | ﹤0.01% | 2136 |
|
|
2021
Q1 | $1.74M | Buy |
60,127
+55,762
| +1,277% | +$1.62M | ﹤0.01% | 2018 |
|
|
2020
Q4 | $113K | Buy |
4,365
+1,079
| +33% | +$27.9K | ﹤0.01% | 3599 |
|
|
2020
Q3 | $101K | Sell |
3,286
-4,449
| -58% | -$137K | ﹤0.01% | 3121 |
|
|
2020
Q2 | $193K | Buy |
7,735
+3,052
| +65% | +$76.2K | ﹤0.01% | 3092 |
|
|
2020
Q1 | $99K | Buy |
4,683
+1,496
| +47% | +$31.6K | ﹤0.01% | 3300 |
|
|
2019
Q4 | $71K | Buy |
3,187
+2,976
| +1,410% | +$66.3K | ﹤0.01% | 3739 |
|
|
2019
Q3 | $5K | Buy |
+211
| New | +$5K | ﹤0.01% | 4765 |
|